Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer
Open Access
- 28 May 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 10 (1), 65
- https://doi.org/10.1186/1476-4598-10-65
Abstract
Background: The research emphasis in anti-cancer drug discovery has always been to search for a drug with the greatest antitumor potential but fewest side effects. This can only be achieved if the drug used is against a specific target located in the tumor cells. In this study, we evaluated Minichromosome Maintenance Protein 7 (MCM7) as a novel therapeutic target in cancer.Results: Immunohistochemical analysis showed that MCM7 was positively stained in 196 of 331 non-small cell lung cancer (NSCLC), 21 of 29 bladder tumor and 25 of 70 liver tumor cases whereas no significant staining was observed in various normal tissues. We also found an elevated expression of MCM7 to be associated with poor prognosis for patients with NSCLC (P= 0.0055). qRT-PCR revealed a higher expression ofMCM7in clinical bladder cancer tissues than in corresponding non-neoplastic tissues (P< 0.0001), and we confirmed that a wide range of cancers also overexpressedMCM7by cDNA microarray analysis. Suppression of MCM7 using specific siRNAs inhibited incorporation of BrdU in lung and bladder cancer cells overexpressing MCM7, and suppressed the growth of those cells more efficiently than that of normal cell strains expressing lower levels of MCM7.Conclusions: Since MCM7 expression was generally low in a number of normal tissues we examined, MCM7 has the characteristics of an ideal candidate for molecular targeted cancer therapy in various tumors and also as a good prognostic biomarker for NSCLC patients.Keywords
This publication has 55 references indexed in Scilit:
- Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancerCancer Treatment Reviews, 2010
- Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathwayMolecular Cancer, 2010
- Maintaining genome stability at the replication forkNature Reviews Molecular Cell Biology, 2010
- Cell Cycle Arrest by Transforming Growth Factor β1 near G1/S Is Mediated by Acute Abrogation of Prereplication Complex Activation Involving an Rb-MCM InteractionMolecular and Cellular Biology, 2010
- Adjuvant Therapy for Colon Cancer: Learning from the Past to Inform the FutureAnnals of Surgical Oncology, 2010
- Activation of WD Repeat and High-Mobility Group Box DNA Binding Protein 1 in Pulmonary and Esophageal CarcinogenesisClinical Cancer Research, 2010
- Replication licensing and cancer — a fatal entanglement?Nature Reviews Cancer, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- ReviewBiological Chemistry, 1998
- Purification of an MCM-containing complex as a component of the DNA replication licensing systemNature, 1995